Desferoxamine and ethyl-3,4-dihydroxybenzoate protect myocardium by activating NOS and generating mitochondrial ROS.
about
The hypoxia-inducible factor pathway, prolyl hydroxylase domain protein inhibitors, and their roles in bone repair and regenerationHypoxia acts through multiple signaling pathways to induce metallothionein transactivation by the metal-responsive transcription factor-1 (MTF-1)Aspirin may promote mitochondrial biogenesis via the production of hydrogen peroxide and the induction of Sirtuin1/PGC-1α genes.HIF-1α in heart: protective mechanisms.Mitochondrial reprogramming through cardiac oxygen sensors in ischaemic heart disease.Nitrite in organ protection.Crosstalk of mitochondria with NADPH oxidase via reactive oxygen and nitrogen species signalling and its role for vascular function.Ethyl 3,4-dihydroxy benzoate, a unique preconditioning agent for alleviating hypoxia-mediated oxidative damage in L6 myoblasts cells.Deferoxamine promotes osteoblastic differentiation in human periodontal ligament cells via the nuclear factor erythroid 2-related factor-mediated antioxidant signaling pathway.Utilization of an in vivo reporter for high throughput identification of branched small molecule regulators of hypoxic adaptation.Effects of Antioxidant Supplements on the Survival and Differentiation of Stem Cells.Mitochondrial monoamine oxidase-A-mediated hydrogen peroxide generation enhances 5-hydroxytryptamine-induced contraction of rat basilar artery.Increase of reactive oxygen species by desferrioxamine during experimental Chagas' disease.HIF-1 reduces ischaemia-reperfusion injury in the heart by targeting the mitochondrial permeability transition pore.Desferrioxamine reduces oxidative stress in the lung contusion
P2860
Q26861237-961549B8-A760-4D68-AA59-B609D2F67A7CQ28385896-C336D3B3-56AD-404A-87DF-62AD54E5104CQ36747143-4CE1A4C1-DB8D-4151-A14C-35A8CA4D2836Q37142770-12730DA5-FB87-457B-9D98-B06484E74A7AQ37777273-265C9E3B-D869-4B0C-A50B-CA7944AAFD3DQ38119258-7388CCF0-2AFF-4502-BA81-8EA7F757B450Q38667506-9C1963BC-991F-4692-A24B-88CABBD83687Q38941722-F92EDC2D-C35A-4078-B68F-A5C37F9B469EQ39083407-CDFA0022-755F-4115-A672-3B84230B0ABBQ39711306-82DD4003-B094-4E49-9D99-BDCB980C7E27Q41099472-89895038-05E4-48FE-AFA0-5A3AAB60E88BQ41149765-47F42C73-A944-4A46-9702-30B9AD5AC9A5Q42135513-655D7A3B-C687-4164-94AA-1887B64E5329Q54334859-5AE76E62-765B-47FC-A90D-AE93CE7CF215Q57961284-9215E10E-F79A-4140-97A0-94D0F0D7EEE3
P2860
Desferoxamine and ethyl-3,4-dihydroxybenzoate protect myocardium by activating NOS and generating mitochondrial ROS.
description
2005 nî lūn-bûn
@nan
2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Desferoxamine and ethyl-3,4-di ...... generating mitochondrial ROS.
@ast
Desferoxamine and ethyl-3,4-di ...... generating mitochondrial ROS.
@en
Desferoxamine and ethyl-3,4-di ...... generating mitochondrial ROS.
@nl
type
label
Desferoxamine and ethyl-3,4-di ...... generating mitochondrial ROS.
@ast
Desferoxamine and ethyl-3,4-di ...... generating mitochondrial ROS.
@en
Desferoxamine and ethyl-3,4-di ...... generating mitochondrial ROS.
@nl
prefLabel
Desferoxamine and ethyl-3,4-di ...... generating mitochondrial ROS.
@ast
Desferoxamine and ethyl-3,4-di ...... generating mitochondrial ROS.
@en
Desferoxamine and ethyl-3,4-di ...... generating mitochondrial ROS.
@nl
P2093
P2860
P1476
Desferoxamine and ethyl-3,4-di ...... generating mitochondrial ROS.
@en
P2093
Barbara Ludolph
James M Downey
Michael V Cohen
Sebastian Philipp
P2860
P304
P356
10.1152/AJPHEART.00472.2005
P577
2005-09-09T00:00:00Z